Introduction Concerns unique to women with breast cancer can include impact of cancer on
body image, sexual well-being and changes in breast appearance and sensation. These …

Background Generic preference-based measures (PBM), though commonly used, may not
be optimal for use in economic evaluations of breast cancer interventions. No breast cancer …

Introduction. Generic preference-based instruments inadequately measure breast cancer
(BrC) health-related quality-of-life preferences given advances in therapy. Our overall …

Breast cancer (BrC) is the most common cancer in women worldwide, however no BrC-
specific preference-based instrument exists. BrC and its treatments can impact patients' …

Objectives Breast cancer (BrC) and its treatments impair health-related quality of life
(HRQoL). Utility is a measure of HRQoL that includes preferences for health outcomes, used …

Women undergoing surgery for primary breast cancer can choose between breast
conserving therapy and mastectomy (with or without breast reconstruction). Patients often …

Objectives This study assessed the content validity of generic and condition-specific
preference-based measures (PBMs) with patients treated for cancer, evaluated against 10 …

In 2006, breast cancer was the third leading cause of death in American women; however,
more women survive breast cancer than any other type of cancer. As the disease …

The important goal in breast cancer treatment is to improve patient quality of life. Due to the
huge economic burden, it is necessary to estimate the health state utility values for different …

Objectives Utility values are a key component of economic evaluations and a stated
requirement of reimbursement bodies when evaluating a new treatment. The current study …